Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1994
Population approaches in drug development. Report on an expert meeting to discuss population pharmacokinetic/pharmacodynamic software
L Aarons, L P Balant, F Mentré, et al.
European Journal of Clinical Pharmacology
|
January 1, 1996
Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies
L Aarons, L P Balant, F Mentre, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 31, 1998
Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children
L Aarons, M Rowland, A Khan, et al.
British Journal of Pharmacology
|
October 21, 2017
Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose
S Y A Cheung, T Rodgers, L Aarons, et al.
The Journal of Biological Chemistry
|
September 15, 1987
An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts
W Kiess, J F Haskell, L Lee, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1999
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria
J A Simpson, R Price, F ter Kuile, et al.
The Journal of Rheumatology
|
February 7, 1998
Ascorbic acid absorption in patients with systemic sclerosis
L S Teh, C W Johns, J L Shaffer, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 23, 2017
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas
Y T Patel, V M Daryani, P Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1
S J Danson, P Johnson, T H Ward, et al.
Mathematical Medicine and Biology : a Journal of the IMA
|
January 14, 2017
Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients
N Eymard, V Volpert, P Kurbatova, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
European Journal of Clinical Pharmacology
|
January 1, 1994
Population approaches in drug development. Report on an expert meeting to discuss population pharmacokinetic/pharmacodynamic software
L Aarons, L P Balant, F Mentré, et al.
European Journal of Clinical Pharmacology
|
January 1, 1996
Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies
L Aarons, L P Balant, F Mentre, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 31, 1998
Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children
L Aarons, M Rowland, A Khan, et al.
British Journal of Pharmacology
|
October 21, 2017
Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose
S Y A Cheung, T Rodgers, L Aarons, et al.
The Journal of Biological Chemistry
|
September 15, 1987
An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts
W Kiess, J F Haskell, L Lee, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1999
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria
J A Simpson, R Price, F ter Kuile, et al.
The Journal of Rheumatology
|
February 7, 1998
Ascorbic acid absorption in patients with systemic sclerosis
L S Teh, C W Johns, J L Shaffer, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 23, 2017
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas
Y T Patel, V M Daryani, P Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1
S J Danson, P Johnson, T H Ward, et al.
Mathematical Medicine and Biology : a Journal of the IMA
|
January 14, 2017
Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients
N Eymard, V Volpert, P Kurbatova, et al.
Page
of 11